Sodium Valproate Tablet
Generic Name |
Sodium Valproate |
---|---|
Strength |
200 mg, 300 mg, 500 mg |
Form |
Tablet |
Packaging |
1 X 10 Tablet |
Therapeutic use |
Antiepileptic |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Sodium Valproate and Valproic Acid Tablet | 200mg + 87mg, 333mg + 145mg, 499.5mg + 217.5mg | Antiepileptic | |
Sodium Valproate Syrup | 200 mg / 5ml | Antiepileptic | |
Sodium Valproate Tablet | 200 mg, 300 mg, 500 mg | Antiepileptic |
Product Description For Sodium Valproate Tablet
products details and uses
Sodium Valproate Tablet Exporter India, Manufacturer and Global Supplier
Sodium Valproate Tablet is a widely prescribed anticonvulsant and mood-stabilizing medication used in the treatment of epilepsy, bipolar disorder, and certain migraine conditions. As a leading Sodium Valproate Tablet Exporter India, we supply high-quality formulations manufactured under WHO-GMP and ISO-certified facilities. Our products are globally trusted for their safety, efficacy, and adherence to international pharmaceutical standards, making us a reliable supplier for hospitals, distributors, and healthcare institutions worldwide.
Sodium Valproate works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which helps stabilize neuronal activity and prevent seizures. It is effective in managing various types of epilepsy, including generalized and partial seizures. Additionally, Sodium Valproate is widely used as a mood stabilizer in bipolar disorder and for the prevention of migraine headaches.
As a reputed Sodium Valproate Tablet Exporter India, we ensure that each batch undergoes stringent quality control testing and is packaged securely to maintain stability during storage and international transport.
Key Uses of Sodium Valproate Tablet
-
Management of epilepsy, including generalized, partial, and absence seizures
-
Mood stabilization in patients with bipolar disorder
-
Prevention of migraine headaches
-
Adjunct therapy in certain neurological disorders as prescribed by a physician
-
Suitable for both adult and pediatric patients under medical supervision
Precautions to Follow
Patients should use Sodium Valproate Tablets strictly under medical supervision. Important precautions include:
-
Take the tablet exactly as prescribed by the healthcare provider
-
Inform your doctor of any history of liver, kidney, or pancreatic disorders
-
Not recommended during pregnancy unless specifically advised by a physician
-
Regular monitoring of liver function, blood counts, and weight is recommended
-
Avoid abrupt discontinuation of therapy to prevent seizure recurrence
-
Consult the doctor before using other medications or supplements concurrently
As a responsible Sodium Valproate Tablet Exporter India, we provide comprehensive product documentation, safety guidelines, and regulatory support for clients worldwide.
Possible Side Effects
Sodium Valproate Tablet is generally well-tolerated, but some patients may experience:
-
Nausea, vomiting, or indigestion
-
Drowsiness or dizziness
-
Tremors or mild hair loss
-
Weight gain
-
Rare but serious side effects such as liver dysfunction, pancreatitis, or blood disorders
Patients should consult their healthcare provider for any persistent or severe side effects.
Why Choose Us as Your Sodium Valproate Tablet Exporter India?
-
WHO-GMP and ISO-certified manufacturing facilities
-
High-quality formulations with strict quality control
-
Compliance with international pharmacopeia standards (IP/BP/USP)
-
Customized packaging and labeling options to meet client requirements
-
Competitive pricing with assured on-time delivery
-
Strong global presence in Asia, Africa, Middle East, and Latin America
As a trusted Sodium Valproate Tablet Exporter India, we supply reliable pharmaceutical solutions to hospitals, distributors, NGOs, and government tenders worldwide.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.